PMID:3132968: Difference between revisions

From EcoliWiki
Jump to navigation Jump to search
/Volumes/r3/t3/ul/working/touchTables/touch_all_tables.php
imported>Wikientrybot
change PMID template to TableEdit version
Line 1: Line 1:
{{RightTOC}}
{{RightTOC}}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.132280.T52239434a617b-->
<!--
******************************************************************************************
*
*  ** PLEASE DON'T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. **
*
****************************************************************************************** -->
{|  id="T52239434a617b"  class=" tableEdit PMID_info_table" 


<span style = 'font-size: large'> '''Badet, B, Vermoote, P and Le Goffic, F'''  (1988) Glucosamine synthetase from Escherichia coli: kinetic mechanism and inhibition by N3-fumaroyl-L-2,3-diaminopropionic derivatives.''Biochemistry'' '''27''':2282-7</span>
|-
!align=left  |Citation
||
'''No author listed'''  (1988) Glucosamine synthetase from Escherichia coli: kinetic mechanism and inhibition by N3-fumaroyl-L-2,3-diaminopropionic derivatives. ''Biochemistry'' '''27''':2282-7
|-
!align=left  |Abstract
||
N3-(4-Methoxyfumaroyl)-L-2,3-diaminopropionic acid (FMDP; 1, R = OMe), a member of a new class of glutamine analogues, has been investigated as an inhibitor of pure Escherichia coli glucosamine synthetase. Product and dead-end inhibition studies indicate an ordered association to the enzyme with the sugar molecule binding prior to substrate or inhibitor. The inactivation exhibits pseudo-first-order kinetics, is irreversible, and occurs faster in the presence of fructose 6-phosphate, a behavior previously reported [Chmara, H., Andruszkiewicz, R., & Borowski, E. (1986) Biochim. Biophys. Acta 870,357] for the partially purified enzyme from Salmonella typhimurium. The ratio kinact/Kirr of 5500 makes compound 1 (R = OMe) one of the most efficient inhibitors of glucosamine synthetase to date. Inhibition occurs with partial covalent incorporation of L-FMDP into glucosamine synthetase. In the presence of fructose 6-phosphate, enzyme inactivation with [2-3H]-DL-FMDP is associated with the incorporation of 0.75 equiv of inhibitor and with the modification of 0.78 thiol residue per enzyme subunit. This result is the first evidence for covalent entrapment of the entire inhibitor molecule following FMDP-mediated glucosamine synthetase inactivation. Preliminary inactivation with 6-diazo-5-oxo-L-norleucine, known to alkylate selectively the NH2-terminal cysteine residue, completely prevents radioactivity incorporation. Therefore, this inhibitor is postulated to covalently modify glucosamine synthetase through direct addition of the thiol nucleophile from the terminal cysteine residue to the Michael acceptor 1, so acting as an affinity label rather than a mechanism-based inhibitor.
|-
!align=left  |Links
||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=3132968 PubMed]


{|{{Prettytable}} align = 'center' width= '70%'
|-
|-
|{{TableHeadingColor}} |'''Abstract''' || N3-(4-Methoxyfumaroyl)-L-2,3-diaminopropionic acid (FMDP; 1, R = OMe), a member of a new class of glutamine analogues, has been investigated as an inhibitor of pure Escherichia coli glucosamine synthetase. Product and dead-end inhibition studies indicate an ordered association to the enzyme with the sugar molecule binding prior to substrate or inhibitor. The inactivation exhibits pseudo-first-order kinetics, is irreversible, and occurs faster in the presence of fructose 6-phosphate, a behavior previously reported [Chmara, H., Andruszkiewicz, R., & Borowski, E. (1986) Biochim. Biophys. Acta 870,357] for the partially purified enzyme from Salmonella typhimurium. The ratio kinact/Kirr of 5500 makes compound 1 (R = OMe) one of the most efficient inhibitors of glucosamine synthetase to date. Inhibition occurs with partial covalent incorporation of L-FMDP into glucosamine synthetase. In the presence of fructose 6-phosphate, enzyme inactivation with [2-3H]-DL-FMDP is associated with the incorporation of 0.75 equiv of inhibitor and with the modification of 0.78 thiol residue per enzyme subunit. This result is the first evidence for covalent entrapment of the entire inhibitor molecule following FMDP-mediated glucosamine synthetase inactivation. Preliminary inactivation with 6-diazo-5-oxo-L-norleucine, known to alkylate selectively the NH2-terminal cysteine residue, completely prevents radioactivity incorporation. Therefore, this inhibitor is postulated to covalently modify glucosamine synthetase through direct addition of the thiol nucleophile from the terminal cysteine residue to the Michael acceptor 1, so acting as an affinity label rather than a mechanism-based inhibitor.
!align=left  |Keywords
</noinclude>
||
|-
Alanine/analogs & derivatives; Escherichia coli/enzymology; Fumarates/chemical synthesis; Fumarates/pharmacology; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)/antagonists & inhibitors; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)/metabolism; Indicators and Reagents; Kinetics; Protein Denaturation; Transaminases/metabolism; beta-Alanine/analogs & derivatives; beta-Alanine/chemical synthesis; beta-Alanine/pharmacology
|{{TableHeadingColor}} nowrap |'''Links''' ||  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=3132968 PubMed]
 
|- class="tableEdit_footer"
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.132280.T52239434a617b&page=132280&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> ||
|}
|}
 
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.132280.T52239434a617b-->
==Significance {{HelpIcon|Help:Literature}} ==
==Significance {{HelpIcon|Help:Literature}} ==
{{LitSignificance}}
{{LitSignificance}}

Revision as of 19:23, 1 September 2013

Citation

No author listed (1988) Glucosamine synthetase from Escherichia coli: kinetic mechanism and inhibition by N3-fumaroyl-L-2,3-diaminopropionic derivatives. Biochemistry 27:2282-7

Abstract

N3-(4-Methoxyfumaroyl)-L-2,3-diaminopropionic acid (FMDP; 1, R = OMe), a member of a new class of glutamine analogues, has been investigated as an inhibitor of pure Escherichia coli glucosamine synthetase. Product and dead-end inhibition studies indicate an ordered association to the enzyme with the sugar molecule binding prior to substrate or inhibitor. The inactivation exhibits pseudo-first-order kinetics, is irreversible, and occurs faster in the presence of fructose 6-phosphate, a behavior previously reported [Chmara, H., Andruszkiewicz, R., & Borowski, E. (1986) Biochim. Biophys. Acta 870,357] for the partially purified enzyme from Salmonella typhimurium. The ratio kinact/Kirr of 5500 makes compound 1 (R = OMe) one of the most efficient inhibitors of glucosamine synthetase to date. Inhibition occurs with partial covalent incorporation of L-FMDP into glucosamine synthetase. In the presence of fructose 6-phosphate, enzyme inactivation with [2-3H]-DL-FMDP is associated with the incorporation of 0.75 equiv of inhibitor and with the modification of 0.78 thiol residue per enzyme subunit. This result is the first evidence for covalent entrapment of the entire inhibitor molecule following FMDP-mediated glucosamine synthetase inactivation. Preliminary inactivation with 6-diazo-5-oxo-L-norleucine, known to alkylate selectively the NH2-terminal cysteine residue, completely prevents radioactivity incorporation. Therefore, this inhibitor is postulated to covalently modify glucosamine synthetase through direct addition of the thiol nucleophile from the terminal cysteine residue to the Michael acceptor 1, so acting as an affinity label rather than a mechanism-based inhibitor.

Links

PubMed

Keywords

Alanine/analogs & derivatives; Escherichia coli/enzymology; Fumarates/chemical synthesis; Fumarates/pharmacology; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)/antagonists & inhibitors; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)/metabolism; Indicators and Reagents; Kinetics; Protein Denaturation; Transaminases/metabolism; beta-Alanine/analogs & derivatives; beta-Alanine/chemical synthesis; beta-Alanine/pharmacology

Significance

You can help EcoliWiki by summarizing why this paper is useful

Useful Materials and Methods

You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.

Annotations

Gene product Qualifier GO ID GO term name Evidence Code with/from Aspect Notes Status

EcoliWiki Links

Add links to pages that link here (e.g. gene, product, method pages)

References

See Help:References for how to manage references in EcoliWiki.